Sharda Cropchem Share Price
Sector: Chemical Manufacturing
633.75 +17.45 (2.83%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
601
Today’s High
652.05
52 Week Low
345
52 Week High
886.35
637.95 +21.80 (3.54%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
613.85
Today’s High
652.50
52 Week Low
345
52 Week High
886.60
Key Metrics
- Market Cap (In Cr) 5689.72
- Beta 0.54
- Div. Yield (%) 1.46
- P/B 2.22
- TTM P/E 16.94
- Peg Ratio -4.08
- Sector P/E 17.01
- D/E 0
- Open Price 601
- Prev Close 616.3
Sharda Cropchem Analysis
Price Analysis
-
1 Week8.88%
-
3 Months18.91%
-
6 Month-24.55%
-
YTD-22.6%
-
1 Year48.63%
Risk Meter
- 61% Low risk
- 61% Moderate risk
- 61% Balanced Risk
- 61% High risk
- 61% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 2
- 2
- 2
- 2
- Buy
- 2
- 2
- 2
- 2
- Hold
- 1
- 1
- 1
- 1
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 5
- 5
- 5
- 5
Sharda Cropchem News
TVS Motor, PNB Housing among 14 stocks that can double in 3 years: DAM Capital
5 min read . 09 Jan 2025Sharda Cropchem Q2 Results: Profit at ₹42.41Cr, Revenue Increased by 33.77% YoY
1 min read . 26 Oct 2024UPL, PI, Rallis, Sharda others: Should you Buy or Sell as monsoon picks pace ?
2 min read . 18 Jul 2024Sharda Cropchem Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 4319.85
- Selling/ General/ Admin Expenses Total
- 52.02
- Depreciation/ Amortization
- 274.66
- Other Operating Expenses Total
- 626.3
- Total Operating Expense
- 3981.04
- Operating Income
- 338.81
- Net Income Before Taxes
- 378.34
- Net Income
- 304.38
- Diluted Normalized EPS
- 33.74
- Period
- 2025
- Total Assets
- 4724.85
- Total Liabilities
- 2224.28
- Total Equity
- 2500.57
- Tangible Book Valueper Share Common Eq
- 162.82
- Period
- 2025
- Cashfrom Operating Activities
- 603.62
- Cashfrom Investing Activities
- -510.06
- Cashfrom Financing Activities
- -67.93
- Net Changein Cash
- 39.87
- Period
- 2024
- Total Revenue
- 3163.02
- Selling/ General/ Admin Expenses Total
- 425.59
- Depreciation/ Amortization
- 267.13
- Other Operating Expenses Total
- 2.77
- Total Operating Expense
- 3147.3
- Operating Income
- 15.73
- Net Income Before Taxes
- 71.87
- Net Income
- 31.88
- Diluted Normalized EPS
- 5.25
- Period
- 2024
- Total Assets
- 4038.32
- Total Liabilities
- 1801.21
- Total Equity
- 2237.12
- Tangible Book Valueper Share Common Eq
- 140.13
- Period
- 2024
- Cashfrom Operating Activities
- 341.3
- Cashfrom Investing Activities
- -393.49
- Cashfrom Financing Activities
- -36.91
- Net Changein Cash
- -89.02
- Period
- 2023
- Total Revenue
- 4045.16
- Selling/ General/ Admin Expenses Total
- 375.56
- Depreciation/ Amortization
- 248.12
- Other Operating Expenses Total
- 0.7
- Total Operating Expense
- 3578.74
- Operating Income
- 466.42
- Net Income Before Taxes
- 430.74
- Net Income
- 341.96
- Diluted Normalized EPS
- 38.95
- Period
- 2023
- Total Assets
- 4350.83
- Total Liabilities
- 2118.81
- Total Equity
- 2232.02
- Tangible Book Valueper Share Common Eq
- 151.31
- Period
- 2023
- Cashfrom Operating Activities
- 328.28
- Cashfrom Investing Activities
- -145.16
- Cashfrom Financing Activities
- -97.1
- Net Changein Cash
- 119.67
- Period
- 2022
- Total Revenue
- 3579.77
- Selling/ General/ Admin Expenses Total
- 297.02
- Depreciation/ Amortization
- 245.33
- Other Operating Expenses Total
- 1.13
- Total Operating Expense
- 3125.62
- Operating Income
- 454.15
- Net Income Before Taxes
- 464.24
- Net Income
- 349.25
- Diluted Normalized EPS
- 41.18
- Period
- 2022
- Total Assets
- 3743.13
- Total Liabilities
- 1830.67
- Total Equity
- 1912.46
- Tangible Book Valueper Share Common Eq
- 124.46
- Period
- 2022
- Cashfrom Operating Activities
- 267.1
- Cashfrom Investing Activities
- -207.89
- Cashfrom Financing Activities
- -90.96
- Net Changein Cash
- -28.86
- Period
- 2021
- Total Revenue
- 2395.61
- Selling/ General/ Admin Expenses Total
- 264.11
- Depreciation/ Amortization
- 170.44
- Other Operating Expenses Total
- 1.07
- Total Operating Expense
- 2149.2
- Operating Income
- 246.41
- Net Income Before Taxes
- 309.45
- Net Income
- 229.17
- Diluted Normalized EPS
- 28.55
- Period
- 2021
- Total Assets
- 2863.86
- Total Liabilities
- 1249.56
- Total Equity
- 1614.3
- Tangible Book Valueper Share Common Eq
- 106.38
- Period
- 2021
- Cashfrom Operating Activities
- 246.37
- Cashfrom Investing Activities
- -281.58
- Cashfrom Financing Activities
- 43.35
- Net Changein Cash
- 7.79
- Period
- 2020
- Total Revenue
- 2003.02
- Selling/ General/ Admin Expenses Total
- 233.5
- Depreciation/ Amortization
- 137.12
- Other Operating Expenses Total
- 0.89
- Total Operating Expense
- 1843.13
- Operating Income
- 159.89
- Net Income Before Taxes
- 184.87
- Net Income
- 164.66
- Diluted Normalized EPS
- 23.65
- Period
- 2020
- Total Assets
- 2347.22
- Total Liabilities
- 944.43
- Total Equity
- 1402.79
- Tangible Book Valueper Share Common Eq
- 94.53
- Period
- 2020
- Cashfrom Operating Activities
- 146.3
- Cashfrom Investing Activities
- -67.76
- Cashfrom Financing Activities
- -59.7
- Net Changein Cash
- 27.12
- Period
- 2019
- Total Revenue
- 2001.14
- Selling/ General/ Admin Expenses Total
- 214.8
- Depreciation/ Amortization
- 99.39
- Other Operating Expenses Total
- 0.82
- Total Operating Expense
- 1728.95
- Operating Income
- 272.2
- Net Income Before Taxes
- 235.03
- Net Income
- 176.34
- Diluted Normalized EPS
- 23.06
- Period
- 2019
- Total Assets
- 2203.35
- Total Liabilities
- 919.44
- Total Equity
- 1283.91
- Tangible Book Valueper Share Common Eq
- 78.24
- Period
- 2019
- Cashfrom Operating Activities
- 556.31
- Cashfrom Investing Activities
- -359.83
- Cashfrom Financing Activities
- -215.54
- Net Changein Cash
- -10.58
- Period
- 2025-03-31
- Total Revenue
- 1828.53
- Selling/ General/ Admin Expenses Total
- 18.23
- Depreciation/ Amortization
- 71.9
- Other Operating Expenses Total
- 233.16
- Total Operating Expense
- 1607.78
- Operating Income
- 220.75
- Net Income Before Taxes
- 256.11
- Net Income
- 203.57
- Diluted Normalized EPS
- 22.57
- Period
- 2025-03-31
- Total Assets
- 4724.85
- Total Liabilities
- 2224.28
- Total Equity
- 2500.57
- Tangible Book Valueper Share Common Eq
- 162.82
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 603.62
- Cashfrom Investing Activities
- -510.06
- Cashfrom Financing Activities
- -67.93
- Net Changein Cash
- 39.87
- Period
- 2024-12-31
- Total Revenue
- 929.33
- Selling/ General/ Admin Expenses Total
- 12.28
- Depreciation/ Amortization
- 68.89
- Other Operating Expenses Total
- 137.77
- Total Operating Expense
- 844.05
- Operating Income
- 85.28
- Net Income Before Taxes
- 45.93
- Net Income
- 31.15
- Diluted Normalized EPS
- 3.45
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 776.89
- Selling/ General/ Admin Expenses Total
- 10.37
- Depreciation/ Amortization
- 69.1
- Other Operating Expenses Total
- 114.69
- Total Operating Expense
- 756.37
- Operating Income
- 20.52
- Net Income Before Taxes
- 45.52
- Net Income
- 42.41
- Diluted Normalized EPS
- 4.7
- Period
- 2024-09-30
- Total Assets
- 3831.95
- Total Liabilities
- 1538.19
- Total Equity
- 2293.76
- Tangible Book Valueper Share Common Eq
- 146.82
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 457.76
- Cashfrom Investing Activities
- -329.27
- Cashfrom Financing Activities
- -34.51
- Net Changein Cash
- 108.73
- Period
- 2024-06-30
- Total Revenue
- 785.11
- Selling/ General/ Admin Expenses Total
- 11.15
- Depreciation/ Amortization
- 64.78
- Other Operating Expenses Total
- 140.68
- Total Operating Expense
- 772.85
- Operating Income
- 12.26
- Net Income Before Taxes
- 30.79
- Net Income
- 27.25
- Diluted Normalized EPS
- 3.02
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 1312.05
- Selling/ General/ Admin Expenses Total
- 19.65
- Depreciation/ Amortization
- 54.26
- Other Operating Expenses Total
- 127.65
- Total Operating Expense
- 1094.67
- Operating Income
- 217.38
- Net Income Before Taxes
- 198.41
- Net Income
- 143.47
- Diluted Normalized EPS
- 18.69
- Period
- 2024-03-31
- Total Assets
- 4038.32
- Total Liabilities
- 1801.21
- Total Equity
- 2237.12
- Tangible Book Valueper Share Common Eq
- 140.13
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 341.3
- Cashfrom Investing Activities
- -393.49
- Cashfrom Financing Activities
- -36.91
- Net Changein Cash
- -89.02
- Period
- 2023-12-31
- Total Revenue
- 632.46
- Selling/ General/ Admin Expenses Total
- 9.36
- Depreciation/ Amortization
- 68.63
- Other Operating Expenses Total
- 110.21
- Total Operating Expense
- 655.05
- Operating Income
- -22.58
- Net Income Before Taxes
- 12.12
- Net Income
- 4.64
- Diluted Normalized EPS
- 0.51
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Sharda Cropchem Technical
Moving Average
SMA
- 5 Day589.8
- 10 Day562.77
- 20 Day561.04
- 50 Day550.14
- 100 Day604.81
- 300 Day626.21
Sharda Cropchem Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Ghcl
- 615.7
- -7.15
- -1.15
- 779.3
- 475.35
- 5895.62
- Rallis India
- 286
- -7.55
- -2.57
- 378.4
- 196
- 5561.81
- Sharda Cropchem
- 633.75
- 17.45
- 2.83
- 886.35
- 345
- 5689.72
- Fischer Medical Ventures
- 850
- 12
- 1.43
- 919
- 513.1
- 5536.43
- Laxmi Organic Industries
- 185.05
- -10.8
- -5.51
- 325.5
- 160.3
- 5139.92
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Ghcl
- 9.74
- 1.75
- 21.45
- 19.66
- Rallis India
- 46.7
- 3.05
- 8.91
- 5.69
- Sharda Cropchem
- 18.67
- 2.27
- 12.63
- 7.18
- Fischer Medical Ventures
- 519.73
- 56.56
- 4.18
- 7.82
- Laxmi Organic Industries
- 45.33
- 3.08
- 13.23
- 5.81
Sharda Cropchem Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 14-May-25
- Audited Results & Final Dividend
- 24-Jan-25
- Quarterly Results & Interim Dividend
- 25-Oct-24
- Quarterly Results
- 23-Jul-24
- Quarterly Results
- 10-May-24
- Audited Results & Final Dividend
- 24-Jan-24
- Quarterly Results
- 21-Oct-23
- Quarterly Results
- 24-Jul-23
- Quarterly Results
- 12-May-23
- Audited Results & Final Dividend
- 24-Jan-23
- Quarterly Results & Interim Dividend
- Meeting Date
- Announced on
- Purpose
- 09-Aug-24
- 03-Jul-24
- AGM
- 17-Jan-24
- 12-Dec-23
- POM
- 02-Aug-23
- 21-Jun-23
- AGM
- 02-Aug-22
- 28-Jun-22
- AGM
- 29-Jul-21
- 29-Jun-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 14-May-25
- -
- -
- 6
- 24-Jan-25
- 06-Feb-25
- 06-Feb-25
- 3
- 10-May-24
- 02-Aug-24
- 02-Aug-24
- 3
- 12-May-23
- 01-Aug-23
- 01-Aug-23
- 3
- 24-Jan-23
- 07-Feb-23
- 07-Feb-23
- 3
- 13-May-22
- 26-Jul-22
- 25-Jul-22
- 3
- 24-Jan-22
- 03-Feb-22
- 02-Feb-22
- 3
- 26-May-21
- 22-Jul-21
- 20-Jul-21
- 3


